New Longevity Science Foundation campaign aims t
Author: Michael
Phase 2 study will assess whether RJx-01 can imp
New Michael J Fox Foundation grant backs a two-p
Alzheimer’s research may be entering its next
The biotech’s ultrasound platform could help o
Rznomics presented Phase 1/2a interim clinical re
Humacyte presented Phase 3 V012 results at the So
Halia Therapeutics announced that the U.S.
Regeneration Biomedical, Inc.
Elysium Health launched Creatine+, a three-in-one